Department of Urology, Hopital Foch, Universite De Versailles - Saint-Quentin En Yvelines, Suresnes, France.
BJU Int. 2013 Jun;111(8):1253-60. doi: 10.1111/j.1464-410X.2012.11664.x. Epub 2013 Jan 17.
To compare the prognoses associated with positive surgical margins (PSMs) according to their urethral, ureteric and/or soft tissue locations in patients with pN0 M0 bladder cancer who have not undergone neoadjuvant chemotherapy.
A retrospective, case-control study was conducted between 1991 and 2011 using data from 17 academic centres in France. A total of 154 patients (cases) with PSMs met the eligibility criteria and were matched according to centre, pT stage, gender, age and urinary diversion method with a population-based sample of 154 patients (controls) from 3651 patients who had undergone cystectomies. The median follow-up period was 23.9 months. Multivariable Cox regression analysis was used to test the effects of PSMs on local recurrence (LR)-free survival, metastatic recurrence (MR)-free survival and cancer-specific survival (CSS).
The 5-year LR-free survival and CSS rates of patients with urethral and soft tissue PSMs were lower than those in the control group. A significant decrease in CSS was associated with soft tissue PSMs (P = 0.003, odds ratio = 0.425, 95% confidence interval 0.283-0.647). The prognosis was not affected in cases of ureteric PSMs.
Soft tissue PSMs were associated with poor CSS rates in patients with pN0 M0 bladder cancer. A correlation between urethrectomy and a reduction of the risk of LR in a urethral PSM setting was observed.
比较未接受新辅助化疗的 pN0 M0 膀胱癌患者中,根据阳性切缘(PSM)位于尿道、输尿管和/或软组织的位置,与预后的相关性。
本研究为 1991 年至 2011 年期间,在法国 17 个学术中心进行的回顾性病例对照研究。共纳入 154 例符合条件的 PSM 患者(病例组),并根据中心、pT 分期、性别、年龄和尿流改道术与接受膀胱切除术的 3651 例患者中基于人群的 154 例患者(对照组)进行匹配。中位随访时间为 23.9 个月。多变量 Cox 回归分析用于检验 PSM 对无局部复发(LR)生存、无转移复发(MR)生存和癌症特异性生存(CSS)的影响。
尿道和软组织 PSM 患者的 5 年无 LR 生存率和 CSS 率低于对照组。CSS 显著下降与软组织 PSM 相关(P = 0.003,优势比 = 0.425,95%置信区间 0.283-0.647)。输尿管 PSM 与预后无关。
pN0 M0 膀胱癌患者中,软组织 PSM 与 CSS 率较低相关。观察到尿道 PSM 中尿道切除术与 LR 风险降低之间存在相关性。